Standout Papers

Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024 2024 202640
  1. Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024 (2024)
    Juliette Paireau, C. Durand et al. Influenza and Other Respiratory Viruses

Immediate Impact

62 standout
Sub-graph 1 of 24

Citing Papers

Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis
2025 Standout
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019
2024 Standout
1 intermediate paper

Works of C. Durand being referenced

Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024
2024 Standout
Influence of Social and Psychosocial Factors on Summer Vacationers’ Sun Protection Behaviors, the PRISME Study, France
2022

Author Peers

Author Last Decade Papers Cites
C. Durand 111 112 99 26 276
Chii‐Dean Lin 123 89 122 21 335
Luiz Euribel Prestes-Carneiro 94 89 85 40 333
Portia Alday 66 135 86 16 328
Mary‐Margaret A. Fill 156 49 87 28 319
Sophia Chiu 72 75 57 20 257
Ahad Mahmud Khan 82 32 84 35 265
S Bracebridge 158 200 31 17 311
Hoang Minh Tu Van 71 59 35 20 238
Shaili Gupta 126 62 34 28 276
Jantien W. Wieringa 46 63 72 13 300

All Works

Loading papers...

Rankless by CCL
2026